FTSE Aim 100: Blue Sky
Global demand for cosmetic treatments is set to push acquisitive aesthetic dermatology specialist Sinclair IS Pharma (SPH:AIM) into profit this year for the first time since it joined Aim in 2011.A shopping spree in the past 12...
06 March 2014